Buscar
-
Exploring the Determinants of Polypharmacy Prescribing and Dispensing Behaviours in Primary Care for the Elderly-Protocol for a Qualitative Study
(International Journal of Environmental Research and Public Health. vol. 18, n° 14, 2021-07-19)Article de revueLibre acceso -
Initiation of multiple-session psychological care in civilians exposed to the November 2015 Paris terrorist attacks
(Archives of Public Health. vol. 81, n° 1, pp. 207, 2023-11-29)Article de revueLibre acceso -
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study
(Diabetologia. vol. 64, n° 4, pp. 778-794, 2021-04)Article de revueLibre acceso -
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
(Acta Neuropathologica. vol. 144, n° 5, pp. 821-842, 2022-11)Article de revueLibre acceso -
Maladie rénale chronique et pratiques néphrologiques en France : leçons de la cohorte CKD-REIN, 2013-2023
(Néphrologie & Thérapeutique. vol. 19, n° 4, pp. 233-250, 2023-08-03)Article de revueLibre acceso -
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
(EBioMedicine. vol. 80, 2022-06)Article de revueLibre acceso -
How mHealth Can Contribute to Improving the Continuum of Care: A Scoping Review Approach to the Case of Human Immunodeficiency Virus in Sub-Saharan Africa
(Public Health Reviews. vol. 43, 2022-09-23)Article de revueLibre acceso -
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide
(Molecular Cancer. vol. 23, n° 1, pp. 38, 2024-02-20)Article de revueLibre acceso -
Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
(Journal of Hematology and Oncology. vol. 15, n° 1, pp. 149, 2022-10-21)Article de revueLibre acceso -
Labor market participation and depression during the COVID-19 pandemic among young adults (18 to 30 years): A nationally representative study in France
(Frontiers in Public Health. vol. 10, 2022-10-24)Article de revueLibre acceso